{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T13:18:35Z","timestamp":1776172715849,"version":"3.50.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> The Wolframin His611Arg polymorphism can influence drug consumption in psychiatric patients with impulsive addictive behavior. This cross-sectional study aims to assess the prevalence of the Wolframin His611Arg polymorphism in MOH, a secondary headache belonging to the spectrum of addictive disorders, episodic migraine (EM), and healthy subjects (HS), and its influence on drug consumption.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> One-hundred and seventy-two EM, 107 MOH, and 83 HS were enrolled and genotyped for the Wolframin His611Arg polymorphism. Subjects were classified as homozygous for allele His (H\/H subjects), homozygous for allele Arg (R\/R subjects), and heterozygous (H\/R subjects), regrouped as R\/R and carriers of allele H (non-R\/R), and matched for clinical data.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> There were no differences in allelic distributions between the three groups (<jats:italic>p<\/jats:italic> = 0.19). Drug consumption and other clinical characteristics were not influenced by the Wolframin His611Arg polymorphism (<jats:italic>p<\/jats:italic> = 0.42; \u03b2 = 0.04) in the EM group. Among the MOH population, R\/R subjects consumed more analgesics (<jats:italic>p<\/jats:italic> &amp;lt; 0.0001; \u03b2  = \u22120.38), particularly combination drugs (<jats:italic>p<\/jats:italic> = 0.0001; <jats:italic>d<\/jats:italic> = 2.32).<\/jats:p><jats:p><jats:bold>Discussion:<\/jats:bold> The Wolframin His611Arg polymorphism has a similar prevalence between the MOH, EM, and HS groups. The presence of the R\/R genotype does not influence symptomatic drug consumption in EM, whereas it determines an increased use of symptomatic drugs in the MOH group, in particular combination drugs (i.e., drugs containing psychoactive compounds).<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Our findings are consistent with the hypothesis that the Wolframin His611Arg polymorphism plays its effect only in the MOH population, influencing the impulsivity control underlying addictive behavior.<\/jats:p>","DOI":"10.3389\/fneur.2020.599517","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T05:11:56Z","timestamp":1611292316000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Genetics Influences Drug Consumption in Medication Overuse Headache, Not in Migraine: Evidence From Wolframin His611Arg Polymorphism Analysis"],"prefix":"10.3389","volume":"11","author":[{"given":"Cherubino","family":"Di Lorenzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Di Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano S.","family":"Grieco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo Maria","family":"Santorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esterina","family":"Pascale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Pierelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"Headache classification committee of the international headache society (IHS) the international classification of headache disorders, 3rd edition","volume":"38","author":"Olesen","year":"2018","journal-title":"Cephalalgia."},{"key":"B2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/0333102413512033","article-title":"Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review","volume":"34","author":"Westergaard","year":"2014","journal-title":"Cephalalgia."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1111\/j.1468-2982.2006.01175.x","article-title":"Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs","volume":"26","author":"Rossi","year":"2006","journal-title":"Cephalalgia."},{"key":"B4","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/j.1468-2982.2008.01810.x","article-title":"Chronic daily headache with medication overuse: a randomized follow-up by neurologist or PCP","volume":"29","author":"Boe","year":"2009","journal-title":"Cephalalgia."},{"key":"B5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1468-2982.2009.01934.x","article-title":"Risk factors in medication-overuse headache: A 1-year follow-up study (care II protocol)","volume":"30","author":"Sances","year":"2010","journal-title":"Cephalalgia"},{"key":"B6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.12688\/f1000research.2-237.v1","article-title":"Nasal decongestant and chronic headache: a case of naphazoline overuse headache?","volume":"2","author":"Di Lorenzo","year":"2013","journal-title":"F1000Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.tips.2004.12.008","article-title":"Medication-overuse headache: similarities with drug addiction","volume":"26","author":"Calabresi","year":"2005","journal-title":"Trends Pharmacol Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1111\/j.1526-4610.2010.01755.x","article-title":"What is the role of dependence-related behavior in medication-overuse headache?","volume":"50","author":"Radat","year":"2010","journal-title":"Headache."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.2217\/Pgs.09.120","article-title":"Pharmacogenomics and medication overuse headache: when the cure may turn to poison","volume":"10","author":"Di Lorenzo","year":"2009","journal-title":"Pharmacogenomics."},{"key":"B10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.neulet.2007.07.037","article-title":"The wolframin His611Arg polymorphism influences medication overuse headache","volume":"424","author":"Di Lorenzo","year":"2007","journal-title":"Neurosci Lett."},{"key":"B11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10194-009-0136-0","article-title":"Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism","volume":"10","author":"Di Lorenzo","year":"2009","journal-title":"J Headache Pain."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1177\/0333102412461890","article-title":"Cortical response to somatosensory stimulation in medication overuse headache patients is influenced by angiotensin converting enzyme (ACE) I\/D genetic polymorphism","volume":"32","author":"Di Lorenzo","year":"2012","journal-title":"Cephalalgia."},{"key":"B13","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/sj.mp.4001681","article-title":"Wolframin mutations and hospitalization for psychiatric illness","volume":"10","author":"Swift","year":"2005","journal-title":"Mol Psychiatr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/ajmg.b.20011","article-title":"Wolfram syndrome and suicide: Evidence for a role of WFS1 in suicidal and impulsive behavior","volume":"119","author":"Sequeira","year":"2003","journal-title":"Am J Med Genet B."},{"key":"B15","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1097\/AUD.0b013e3182944db7","article-title":"Audiologic and vestibular findings in Wolfram Syndrome","volume":"34","author":"Karzon","year":"2013","journal-title":"Ear Hearing."},{"key":"B16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jaapos.2014.07.162","article-title":"Ophthalmologic correlates of disease severity in children and adolescents with Wolfram syndrome","volume":"18","author":"Hoekel","year":"2014","journal-title":"J Aapos."},{"key":"B17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/2441","article-title":"A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome)","volume":"20","author":"Inoue","year":"1998","journal-title":"Nat Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0197-2456(98)00037-3","article-title":"Power and sample size calculations for studies involving linear regression","volume":"19","author":"Dupont","year":"1998","journal-title":"Control Clin Trials."},{"key":"B19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/01.QMH.0000267447.55500.57","article-title":"Statistical and nonstatistical significance: implications for health care researchers","volume":"16","author":"Baghi","year":"2007","journal-title":"Qual Manag Health Care."},{"key":"B20","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1469-185X.2007.00027.x","article-title":"Effect size, confidence interval and statistical significance: a practical guide for biologists","volume":"82","author":"Nakagawa","year":"2007","journal-title":"Biol Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1021\/bi900260y","article-title":"Identification and Characterization of Wolframin, the Product of the Wolfram Syndrome Gene (WFS1), as a Novel Calmodulin-Binding Protein","volume":"48","author":"Yurimoto","year":"2009","journal-title":"Biochemistry."},{"key":"B22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ijdevneu.2014.03.009","article-title":"Initiation and developmental dynamics of Wfs1 expression in the context of neural differentiation and ER stress in mouse forebrain","volume":"35","author":"Tekko","year":"2014","journal-title":"Int J Dev Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cne.21734","article-title":"Wolfram syndrome 1 (Wfs1) gene expression in the normal mouse visual system","volume":"510","author":"Kawano","year":"2008","journal-title":"J Comp Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1046\/j.1601-183x.2003.00047.x","article-title":"A screen for genes induced in the amygdaloid area during cat odor exposure","volume":"3","author":"Koks","year":"2004","journal-title":"Genes Brain Behav."},{"key":"B25","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bbr.2013.01.046","article-title":"Evidence for impaired function of dopaminergic system in Wfs1-deficient mice","volume":"244","author":"Visnapuu","year":"2013","journal-title":"Behav Brain Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.neulet.2009.05.054","article-title":"Relation between increased anxiety and reduced expression of alpha1 and alpha2 subunits of GABA(A) receptors in Wfs1-deficient mice","volume":"460","author":"Raud","year":"2009","journal-title":"Neurosci Lett."},{"key":"B27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.bbr.2008.11.007","article-title":"Wfs1-deficient mice display impaired behavioural adaptation in stressful environment","volume":"198","author":"Luuk","year":"2009","journal-title":"Behav Brain Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/sj.mp.4002109","article-title":"WFS1 gene as a putative biomarker for development of post-traumatic syndrome in an animal model","volume":"14","author":"Kesner","year":"2009","journal-title":"Mol Psychiatr."},{"key":"B29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neures.2008.02.002","article-title":"Behavioral and gene expression analyse mice as a possible animal model of of Wfs1 knockout mice as a possible animal model moods disorder","volume":"61","author":"Kato","year":"2008","journal-title":"Neurosci Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/0333102418784747","article-title":"Short-term cortical synaptic depression\/potentiation mechanisms in chronic migraine patients with or without medication overuse","volume":"39","author":"Cortese","year":"2019","journal-title":"Cephalalgia."},{"key":"B31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0376-8716(95)01121-E","article-title":"The role of calcium channels in drug-dependence","volume":"38","author":"Little","year":"1995","journal-title":"Drug Alcohol Depen."},{"key":"B32","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.euroneuro.2003.08.005","article-title":"Neuroadaptive mechanisms of addiction: studies on the extended amygdala","volume":"13","author":"Koob","year":"2003","journal-title":"Eur Neuropsychopharm."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1172\/Jci26436","article-title":"The anxious amygdala: CREB signaling and predisposition to anxiety and alcoholism","volume":"115","author":"Wand","year":"2005","journal-title":"J Clin Invest."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1016\/j.peptides.2006.07.011","article-title":"Endogenous opiates and behavior: 2005","volume":"27","author":"Bodnar","year":"2006","journal-title":"Peptides."},{"key":"B35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12017-008-8056-8","article-title":"Common variations in 4p locus are related to male completed suicide","volume":"11","author":"Must","year":"2009","journal-title":"Neuromol Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.jpain.2012.05.014","article-title":"The Val66Met polymorphism of the BDNF gene influences trigeminal pain-related evoked responses","volume":"13","author":"Di Lorenzo","year":"2012","journal-title":"J Pain."},{"key":"B37","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/ejn.12458","article-title":"The upstream Variable Number Tandem Repeat polymorphism of the monoamine oxidase type A gene influences trigeminal pain-related evoked responses","volume":"39","author":"Di Lorenzo","year":"2014","journal-title":"Eur J Neurosci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ceca.2005.01.016","article-title":"Calcium regulation of actin dynamics in dendritic spines","volume":"37","author":"Oertner","year":"2005","journal-title":"Cell Calcium."},{"key":"B39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2174\/1874467210902010083","article-title":"Group I metabotropic glutamate receptors: involvement in drug-seeking and drug-induced plasticity","volume":"2","author":"Bird","year":"2009","journal-title":"Curr Mol Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1208\/s12248-009-9085-4","article-title":"Glial-neuronal interactions-implications for plasticity and drug addiction","volume":"11","author":"Vijayaraghavan","year":"2009","journal-title":"AAPS J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fphar.2013.00172","article-title":"Convergence of dopamine and glutamate signaling onto striatal ERK activation in response to drugs of abuse","volume":"4","author":"Cahill","year":"2014","journal-title":"Front Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s10072-019-03735-4","article-title":"Withdrawal from acute medication normalises short-term cortical synaptic potentiation in medication overuse headache","volume":"40","author":"Cortese","year":"2019","journal-title":"Neurol Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1471-2377-10-126","article-title":"Abnormal cortical responses to somatosensory stimulation in medication-overuse headache","volume":"10","author":"Coppola","year":"2010","journal-title":"BMC Neurol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1177\/0333102411415877","article-title":"Drug-induced changes in cortical inhibition in medication overuse headache","volume":"31","author":"Curra","year":"2011","journal-title":"Cephalalgia."},{"key":"B45","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10194-012-0478-x","article-title":"Migraine headache: a review of the molecular genetics of a common disorder","volume":"13","author":"Di Lorenzo","year":"2012","journal-title":"J Headache Pain."},{"key":"B46","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2217\/Pgs.14.20","article-title":"Pharmacogenomics of episodic migraine: time has come for step forward","volume":"15","author":"Viana","year":"2014","journal-title":"Pharmacogenomics."},{"key":"B47","doi-asserted-by":"publisher","first-page":"11048","DOI":"10.1523\/Jneurosci.3986-13.2014","article-title":"A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the mu opioid receptor gene OPRM1 via hnRNPH interactions","volume":"34","author":"Xu","year":"2014","journal-title":"J Neurosci."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.599517\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T05:11:58Z","timestamp":1611292318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.599517\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,22]]},"references-count":47,"alternative-id":["10.3389\/fneur.2020.599517"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.599517","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,22]]},"article-number":"599517"}}